A prediction tool for nosocomial multi-drug resistant gram-negative bacilli infections in critically ill patients - prospective observational study

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Vasudevan, Anupama ^a   Mukhopadhyay, Amartya ^a   Li, Jialiang ^b   Yuen, Eugene Goh Yu ^a   Tambyah, Paul Ananth ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antibiotic resistance; Bacteremia; Gram Negative Bacteria; Intensive care unit; Nosocomial Infection; Prediction tool

Indexed keywords

CARBAPENEM DERIVATIVE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; AREA UNDER THE CURVE; ARTICLE; BACILLACEAE INFECTION; BACTEREMIA; BACTERIAL COLONIZATION; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIALYSIS; END STAGE RENAL DISEASE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE INFECTION; GSDCS SCORE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOSOCOMIAL MULTIDRUG RESISTANT GRAM NEGATIVE BACILLI INFECTION; OBSERVATIONAL STUDY; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ACINETOBACTER INFECTIONS; AGED; CRITICAL ILLNESS; CROSS INFECTION; DECISION SUPPORT SYSTEM; ESCHERICHIA COLI INFECTIONS; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; KIDNEY FAILURE, CHRONIC; KLEBSIELLA INFECTIONS; LENGTH OF STAY; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PHYSIOLOGY; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; RENAL REPLACEMENT THERAPY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SURGERY; URINARY TRACT INFECTIONS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CARBAPENEMS; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; DECISION SUPPORT TECHNIQUES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, CHRONIC; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RENAL DIALYSIS; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINARY TRACT INFECTIONS;

EID: 84965189710     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0615-z     Document Type: Article

References (53)

1. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, Sprenger M: Antimicrobial resistance. Is a major threat to public health. BMJ 1998, 317:609-610.
2. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J: Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1-12.
3. World Health Day: Media Fact Sheet, Antimicrobial resistance: no action today, no cure tomorrow [http://www.cdc.gov/media/releases/2011/f0407_antimicrobialresistance.pdf]
4. Integrated Task Force on Antimicrobial Resistance: A public health action plan to combat antimicrobial resistance [http://www.cdc.gov/drugresistance/pdf/public-health-action-plan-combat-antimicrobialresistance. pdf]
5. European Centre for Disease Prevention and Control: ECDC Strategic Multi-Annual Programme 2007-2013: Public Health Activities, Disease-Specific Programmes and MultilateralPartnerships. ECDC; 2008:48 [http://www.ecdc. europa.eu/en/aboutus/Key%20Documents/07-13_KD_Strategic_ multiannual_programme.pdf]
6. Donowitz LG, Wenzel RP, Hoyt JW: High risk of hospital-acquired infection in the ICU patient. Crit Care Med 1982, 10:355-357.
7. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995, 274:639-644.
8. Flaherty JP, Weinstein RA: Nosocomial infection caused by antibioticresistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol 1996, 17:236-248.
9. Van Duijn PJ, Dautzenberg MJD, Oostdijk EAN: Recent trends in antibiotic resistance in European ICUs. Curr Opin Crit Care 2011, 17:658-665.
10. European Centre for Disease Prevention and Control: Antimicrobial resistance surveillance in Europe 2009. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2010, [http://www.ecdc.europa.eu/en/publications/Publications/1011_SUR_ annual_EARS_Net_2009.pdf]
11. Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F, Cuellar LE, Madani N, Mitrev Z, Dueñas L, Navoa-Ng JA, Garcell HG, Raka L, Hidalgo RF, Medeiros EA, Kanj SS, Abubakar S, Nercelles P, Pratesi RD: International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control 2008, 36:627-637.
12. National Nosocomial Infections Surveillance System: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004, 32:470-485.
13. Chung DR, Song J-H, Kim SH, Thamlikitkul V, Huang S-G, Wang H, So TM-K, Yasin RMD, Hsueh P-R, Carlos CC, Hsu LY, Buntaran L, Lalitha MK, Kim MJ, Choi JY, Kim SI, Ko KS, Kang C-I, Peck KR: High prevalence of multidrugresistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 2011, 184:1409-1417.
14. Hsu L-Y, Tan T-Y, Jureen R, Koh T-H, Krishnan P, Tzer-Pin Lin R, Wen-Sin Tee N, Tambyah PA: Antimicrobial drug resistance in Singapore hospitals. Emerg Infect Dis 2007, 13:1944-1947.
15. Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D: Ready for a world without antibiotics? The Pensières antibiotic resistance call to action. Antimicrob Resist Infect Control 2012, 1:11.
16. Kollef MH, Golan Y, Micek ST, Shorr AF, Restrepo MI: Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections-proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis 2011, 53 Suppl 2:S33-S55. quiz S56-8.
17. McGowan JE: Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Med 2006, 119(6 Suppl 1): S29-S36. discussion S62-70.
18. Dortch MJ, Fleming SB, Kauffmann RM, Dossett LA, Talbot TR, May AK: Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections. Surg Infect (Larchmt) 2011, 12:15-25.
19. Lautenbach E, Larosa LA, Kasbekar N, Peng HP, Maniglia RJ, Fishman NO: Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use. Arch Intern Med 2003, 163:601-605.
20. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ: Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003, 163:972-978.
21. Erbay A, Bodur H, Akinci E, Colpan A: Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey. J Hosp Infect 2005, 59:53-61.
22. Alexiou VG, Michalopoulos A, Makris GC, Peppas G, Samonis G, Falagas ME: Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study. Eur J Clin Microbiol Infect Dis 2012, 31(4):557-566.
23. Kim SY, Jung JY, Kang YA, Lim JE, Kim EY, Lee SK, Park SC, Chung KS, Park BH, Kim YS, Kim SK, Chang J, Park MS: Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit. J Korean Med Sci 2012, 27:939-947.
24. Tumbarello M, Repetto E, Trecarichi EM, Bernardini C, De Pascale G, Parisini A, Rossi M, Molinari MP, Spanu T, Viscoli C, Cauda R, Bassetti M: Multidrugresistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect 2011, 139:1740-1749.
25. Varley AJ, Williams H, Fletcher S: Antibiotic resistance in the intensive care unit. Contin Educ Anaesthesia, Crit Care Pain 2009, 9:114-118.
26. WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care. 2009 PubMed-NCBI [http://www.ncbi.nlm.nih.gov/pubmed/23805438]
27. Ong BKC: Leveraging on information technology to enhance patient care: a doctor's perspective of implementation in a Singapore academic hospital. Ann Acad Med Singapore 2002, 31:707-711.
28. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL: Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
29. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
30. Vasudevan A, Chuang L, Jialiang L, Mukhopadhyay A, Goh EY-Y, Tambyah PA: Inappropriate empirical antimicrobial therapy for multidrug-resistant organisms in critically ill patients with pneumonia is not an independent risk factor for mortality: results of a prospective observational study of 758 patients. J Glob Antimicrob Resist 2013, 1:123-130.
31. Rotstein C, Evans G, Born A, Grossman R, Light RB, Magder S, McTaggart B, Weiss K, Zhanel GG: Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol 2008, 19:19-53.
32. Bone RC: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest J 1992, 101:1644.
33. Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L: The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 2005, 38:404-415.
34. Hosmer DW, Lemenshow S: Applied logistic regression. 2nd. New York: Wiley; 2000 [Wiley series in probability and mathematical statistics].
35. Akinci E, Colpan A, Bodur H, Balaban N, Erbay A: Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections. J Hosp Infect 2005, 59:317-323.
36. Wasson JH, Sox HC, Neff RKGL: Clinical prediction rules. Applications and methodological standards. N Engl J Med 1985, 313:793-799.
37. Brusselaers N, Vogelaers D, Blot S: The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care 2011, 1:47.
38. American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
39. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH: Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122:262-268.
40. Kollef MH, Ward S: The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998, 113:412-420.
41. Álvarez-Lerma F, Grau S: Management of antimicrobial use in the intensive care unit. Drugs 2012, 72:447-470.
42. Malacarne P, Rossi C, Bertolini G: Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study. J Antimicrob Chemother 2004, 54:221-224.
43. Donaldson AD, Razak L, Liang LJ, Fisher DA, Tambyah PA: Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter? Int J Antimicrob Agents 2009, 34:246-251.
44. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
45. Playford EG, Craig JC, Iredell JR: Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007, 65:204-211.
46. Pop-Vicas A, Strom J, Stanley K, D'Agata EMC: Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis. Clin J Am Soc Nephrol 2008, 3:752-758.
47. Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Papas V, Pitsiolis T, Tsakris A, Nanas S, Roussos C: Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients. Intensive Care Med 2013, 39:1253-1261.
48. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM: Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991, 143(5 Pt 1):1121-1129.
49. Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, Palizas F, Menga G, Rios F, Apezteguia C: Resolution of ventilatorassociated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003, 31:676-682.
50. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL: Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162(2 Pt 1):505-511.
51. Shorr AF, Zilberberg MD, Micek ST, Kollef MH: Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 2008, 168:2205-2210.
52. Lodise TP, Miller CD, Graves J, Furuno JP, McGregor JC, Lomaestro B, Graffunder E, McNutt L-A: Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob Agents Chemother 2007, 51:417-422.
53. McGinn T, Jervis R, Wisnivesky J, Keitz S, Wyer PC: Tips for teachers of evidence-based medicine: clinical prediction rules (CPRs) and estimating pretest probability. J Gen Intern Med 2008, 23:1261-1268.